PharmaShots

APRIL 25, 2023

Founded Year: 2008 Total Employees: ~2110 Headquarters: Dublin, Ireland Market Cap: $1.7M Stock Exchange: NYSE Novo Nordisk is a global healthcare biopharma company focusing on its mission to drive change and fight against diabetes and other serious chronic diseases such as obesity, rare blood, and rare endocrine diseases.

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Diabetes Packaging Immunity 40

PharmaShots

APRIL 13, 2023

In 2008, Johnson acquired tissue sealing system developer, SurgRx Pfizer's pharmaceutical segment revenue increased after the acquisitions of Serenex, Encysive Pharmaceuticals, CovX, and Coley Pharmaceuticals Novartis reported a total revenue of $41.4B, under which, its pharmaceutical division faced a revenue loss of $2.6B

Biosimilars 40

Biosimilars Vaccines Pharmaceutical Companies Pharmaceutical Companies 40

PharmaShots

JANUARY 31, 2023

Founded Year: 2008 No. The Company's premier line of smart safety syringes, Sharps Provensa, prevents accidental needlestick injuries, prevents needle reuse, and minimizes drug and vaccine waste—all while maintaining the intuitive simplicity of conventional syringes. In Sep’22 stakeholders exercised 0.7M of Shares: 2.1M

Vaccines 40

Vaccines Immunity Immunization Diabetes 40

Quality Matters

OCTOBER 13, 2021

By enabling a multi-manufacturer environment, USP standards have helped increase the availability of medicines to treat cardiovascular disease, cancer, diabetes, mental health and many other conditions. Since manufacturers know the precise quality specifications, standards help make the approval process for generic medicines more efficient.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Adverse Reactions Prescription Filling Compounding 52

Putting Patients First Blog

SEPTEMBER 9, 2024

Mental health and substance use disorders significantly impact the quality of life and overall health of Medicare beneficiaries, often coexisting with other chronic conditions such as diabetes, cardiovascular disease, and chronic pain. The empirical evidence for the telemedicine intervention in diabetes management. 13 Bashshur, R.,

Insurance Coverage and Processing 40

Insurance Coverage and Processing Documentation Vaccines Communication 40

The Thyroid Pharmacist

NOVEMBER 8, 2024

15] Researchers believe that infections such as MAP might be a common pathogenic trigger behind multiple autoimmune and other diseases (including Hashimoto’s, rheumatoid arthritis, Crohn’s disease, type 1 diabetes, and possibly psoriasis) in genetically susceptible individuals. [16] Egyptian Journal of Obesity, Diabetes and Endocrinology.

Immunity 73

Immunity Immunization Diabetes Adverse Reactions 73

Express Pharma

JANUARY 3, 2025

While India was able to leverage the 2008 patent cliff of small molecules, the same playbook will not work for biologics and biosimilars. One of the trends set to define 2025, and the decade ahead, is the 2022-30 patent cliff, and the gradual shift in biopharma revenues from small to large molecules. Omicron BA.5).

Biosimilars 105

Biosimilars Vaccines Diabetes 105